Literature DB >> 7531208

Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma.

R Raqib1, B Wretlind, J Andersson, A A Lindberg.   

Abstract

Stool and plasma cytokine levels in 60 adults with acute shigellosis were studied by EIA at various intervals (0-45 days) after onset of diarrhea. Cytokine levels correlated with severity of disease. Significantly higher levels of proinflammatory cytokines peaked at onset of disease in stool of patients with severe disease (P < .05). In contrast, interferon-gamma (IFN-gamma) levels, depressed at disease onset, progressively increased during the convalescent stage. Concomitantly obtained plasma cytokine levels were 100 times lower than levels in stool. Controls in Shigella-endemic areas (n = 42) had persistently significantly higher levels of IFN-gamma and interleukin-1 receptor antagonist in both stool and plasma. The lack of host defense activity against shigellosis may be linked to delayed recovery of IFN-gamma. This cytokine may play an important role in elimination of the infection and development of immunity against shigellosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7531208     DOI: 10.1093/infdis/171.2.376

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  42 in total

1.  Usefulness of fecal lactoferrin in predicting and monitoring the clinical severity of infectious diarrhea.

Authors:  Chien-Chang Chen; Chee-Jen Chang; Tzou-Yien Lin; Ming-Wei Lai; Hsun-Chin Chao; Man-Shan Kong
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

2.  Bidirectional concentration-dependent effects of tumor necrosis factor alpha in Shigella dysenteriae-related seizures.

Authors:  Yael Yuhas; Abraham Weizman; Shai Ashkenazi
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 3.  Shigella: a model of virulence regulation in vivo.

Authors:  Benoit Marteyn; Anastasia Gazi; Philippe Sansonetti
Journal:  Gut Microbes       Date:  2012-03-01

Review 4.  Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Authors:  Myron M Levine; Karen L Kotloff; Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

5.  Local entrapment of interferon gamma in the recovery from Shigella dysenteriae type 1 infection.

Authors:  R Raqib; A Ljungdahl; A A Lindberg; U Andersson; J Andersson
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

6.  Thinking outside the Osp(G)--kinase activation by E2-ubiquitin.

Authors:  Maarten F de Jong; Neal M Alto
Journal:  EMBO J       Date:  2014-01-30       Impact factor: 11.598

7.  Identification of epitope and surface-exposed domains of Shigella flexneri invasion plasmid antigen D (IpaD).

Authors:  K R Turbyfill; J A Mertz; C P Mallett; E V Oaks
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

8.  Quantitative assessment of IgG and IgA subclass producing cells in rectal mucosa during shigellosis.

Authors:  D Islam; B Veress; P K Bardhan; A A Lindberg; B Christensson
Journal:  J Clin Pathol       Date:  1997-06       Impact factor: 3.411

9.  Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells.

Authors:  C M Thorpe; B P Hurley; L L Lincicome; M S Jacewicz; G T Keusch; D W Acheson
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

10.  Selective deletion of CD8(+) cells upregulated by caspases-1 via IL-18 in mice immunized with major outer membrane protein of Shigella dysenteriae 1 following infection.

Authors:  Ashim Kumar Bagchi; Ajoy Kumar Sinha; Rushita Adhikari; Pradip Maiti; Joydeep Mukherjee; Arpita Panda; Dhira Rani Saha
Journal:  J Clin Immunol       Date:  2010-01-19       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.